Detalhe da pesquisa
1.
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.
Cancer Immunol Immunother
; 73(7): 117, 2024 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38713229
2.
BPIFB1 promotes metastasis of hormone receptor-positive breast cancer via inducing macrophage M2-like polarization.
Cancer Sci
; 114(11): 4157-4171, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37702269
3.
Survival Outcomes of Breast-Conserving Therapy versus Mastectomy in Early-Stage Breast Cancer, Including Centrally Located Breast Cancer: A SEER-Based Study.
Breast J
; 2022: 5325556, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36101863
4.
Identification of a PANoptosis-related Gene Signature for Predicting the Prognosis, Tumor Microenvironment and Therapy Response in Breast Cancer.
J Cancer
; 15(2): 428-443, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38169571
5.
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.
Breast Cancer
; 2024 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38643430
6.
Inhibition of lncRNA PCAT19 promotes breast cancer proliferation.
Cancer Med
; 12(10): 11971-11982, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36992525
7.
Construction of an immunogenic cell death-based risk score prognosis model in breast cancer.
Front Genet
; 13: 1069921, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36583019
8.
LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis.
J Oncol
; 2022: 9999343, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35518784